Stem Cell Treatment for Epstein-Barr is an Option
Infectious mononucleosis (also known as EBV infectious mononucleosis) is an infectious, widespread viral disease caused by the Epstein–Barr Virus (EBV), one type of herpes virus, to which more than 90% of adults have been exposed. More than 90% of the population is infected with Epstein-Barr virus (EBV), which is an enveloped herpesvirus. EBV infection in
immunocompetent individuals causes a mild self-limiting illness, but the virus persists lifelong as a latent infection in B cells and spreads in
the community by productive replication in B cells and oral epithelial cells. Rickinson AB: EBV infection and EBV-associated tumors, in Minson AC, Neil JC, McRae MA (eds): Viruses and Cancer. Cambridge, United Kingdom: Cambridge University Press, 1994, pp 81-100
SIRM provides Stem Cell Treatments as an option...
Occasionally, the symptoms can recur at a later period. Most people are exposed to the virus as children, when the disease produces no noticeable or only flu-like symptoms. In developing countries, people are exposed to the virus in early childhood more often than in developed countries. As a result, the disease in its observable form is more common in developed countries. It is most common among adolescents and young adults.
Especially in adolescents and young adults, the disease is characterized by fever, sore throat and fatigue, along with several other possible signs and symptoms. It is primarily diagnosed by observation of symptoms, but suspicion can be confirmed by several diagnostic tests.
Stem Cell Treatment for Epstein-Barr
NIH Streaming Database: